Phase 1 trial commences Q1, 2022 for Emyrias ultra-pure CBD
Released
Latest announcements
Ask a question
Your question will be sent privately to Emyria. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Emyria a question about this announcement.